1996Rinsho yakuri/Japanese Journal of Clinical Pharmacology and TherapeuticsOpen access

Effect of Dihydropyridine Calcium Channel Blockers on the Plasma Digoxin Level.

Yasuaki Hashimoto, Akira Shimizu, T. Kuroda, Masanori Hayakawa, Kouziro AWANO, Ryuichi Emoto, Mitsuyasu Terashima, H Nakamura, Hisashi Fukuzaki

Open full text 6 citations

Abstract

The effects of four dihydropyridine calcium channel blockers (nifedipine, nisoldipine, nitrendipine and manidipine) on the plasma digoxin level were studied in patients and the effects of nitrendipine and nisoldipine were compared in beagle dogs . In the clinical study, the mean plasma concentration of digoxin was significantly higher during combined administration with nitrendipine than with the other calcium channel blockers. In addition, the digoxin level was decreased by about 50% at one month after changing the calcium channel blocker from nitrendipine to nisoldipine. In dogs, combined administration with nitrendipine resulted in a significantly higher plasma digoxin level after 2 and 4 hrs and a significantly larger mean area under the plasma concentration time curvecompared with administration without nitrendipine (p<0.05). These findings demonstrate that the plasma concentration of digoxin is influenced by dihydropyridine calcium channel blockers, with nitrendipine increasing the digoxin level more than the other agents tested. Since digoxin has a narrow therapeutic range, careful monitoring of the plasma digoxin level during combined therapy with nitrendipine is suggested to minimize the risk of toxicity.

Open-access reader

About this research paper

What this paper is about

The effects of four dihydropyridine calcium channel blockers (nifedipine, nisoldipine, nitrendipine and manidipine) on the plasma digoxin level were studied in patients and the effects of nitrendipine and nisoldipine were compared in beagle dogs . In the clinical study, the mean plasma concentration of digoxin was significantly higher during combined administration with nitrendipine than with the other calcium channel blockers. In addition, the digoxin level was decreased by about 50% at one month after changing the calcium channel blocker from nitrendipine to nisoldipine. In dogs, combined administration with nitrendipine resulted in a significantly higher plasma digoxin level after 2 and 4 hrs and a significantly larger mean area under the plasma concentration time curvecompared with administration without nitrendipine (p<0.05). These findings demonstrate that the plasma concentration of digoxin is influenced by dihydropyridine calcium channel blockers, with nitrendipine increasing the digoxin level more than the other agents tested. Since digoxin has a narrow therapeutic range, careful monitoring of the plasma digoxin level during combined therapy with nitrendipine is suggested to minimize the risk of toxicity.

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The effects of four dihydropyridine calcium channel blockers (nifedipine, nisoldipine, nitrendipine and manidipine) on the plasma digoxin level were studied in patients and the effects of nitrendipine and nisoldipine were compared in beagle dogs . In the clinical study, the mean plasma concentration of digoxin was significantly higher during combined administration with nitrendipine than with the other calcium channel blockers. In addition, the digoxin level was decreased by about 50% at one month after changing the calcium channel blocker from nitrendipine to nisoldipine. In dogs, combined administration with nitrendipine resulted in a significantly higher plasma digoxin level after 2 and 4 hrs and a significantly larger mean area under the plasma concentration time curvecompared with administration without nitrendipine (p<0.05). These findings demonstrate that the plasma concentration of digoxin is influenced by dihydropyridine calcium channel blockers, with nitrendipine increasing the digoxin level more than the other agents tested. Since digoxin has a narrow therapeutic range, careful monitoring of the plasma digoxin level during combined therapy with nitrendipine is suggested to minimize the risk of toxicity.

Key concepts: Nitrendipine, Nisoldipine, Digoxin, Dihydropyridine, Nifedipine, Calcium channel, Medicine, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of Dihydropyridine Calcium Channel Blockers on the Plasma Digoxin Level. — Research Paper | ScholarLens